AR023815A1 - Solucion oral de prucalopride - Google Patents

Solucion oral de prucalopride

Info

Publication number
AR023815A1
AR023815A1 ARP000102075A ARP000102075A AR023815A1 AR 023815 A1 AR023815 A1 AR 023815A1 AR P000102075 A ARP000102075 A AR P000102075A AR P000102075 A ARP000102075 A AR P000102075A AR 023815 A1 AR023815 A1 AR 023815A1
Authority
AR
Argentina
Prior art keywords
prucalopride
oral
solution
pharmaceutically acceptable
aqueous solution
Prior art date
Application number
ARP000102075A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR023815A1 publication Critical patent/AR023815A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Una solucion acuosa oral que comprende prucalopride o sus sales de adicion ácida farmacéuticamente aceptables que tienen buenas propiedades organolépticas,y además contiene ácido benzoico.
ARP000102075A 1999-04-29 2000-04-28 Solucion oral de prucalopride AR023815A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29

Publications (1)

Publication Number Publication Date
AR023815A1 true AR023815A1 (es) 2002-09-04

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102075A AR023815A1 (es) 1999-04-29 2000-04-28 Solucion oral de prucalopride

Country Status (36)

Country Link
US (1) US6413988B1 (es)
EP (1) EP1176982B1 (es)
JP (1) JP4773619B2 (es)
KR (1) KR100669175B1 (es)
CN (1) CN1165345C (es)
AR (1) AR023815A1 (es)
AT (1) ATE254929T1 (es)
AU (1) AU770073B2 (es)
BG (1) BG65061B1 (es)
BR (1) BRPI0010150B8 (es)
CA (1) CA2371178C (es)
CZ (1) CZ294070B6 (es)
DE (1) DE60006799T2 (es)
DK (1) DK1176982T3 (es)
EA (1) EA003904B1 (es)
EE (1) EE05264B1 (es)
ES (1) ES2211546T3 (es)
HK (1) HK1045950B (es)
HR (1) HRP20010764B1 (es)
HU (1) HU228924B1 (es)
ID (1) ID30397A (es)
IL (2) IL146152A0 (es)
JO (1) JO2181B1 (es)
MX (1) MXPA01010953A (es)
MY (1) MY119880A (es)
NO (1) NO331448B1 (es)
NZ (1) NZ515119A (es)
PL (1) PL195674B1 (es)
PT (1) PT1176982E (es)
SI (1) SI1176982T1 (es)
SK (1) SK284847B6 (es)
TR (1) TR200103121T2 (es)
TW (1) TW592709B (es)
UA (1) UA68426C2 (es)
WO (1) WO2000066170A1 (es)
ZA (1) ZA200108820B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
JP2004513969A (ja) * 2000-11-24 2004-05-13 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 腸洗浄を促進するための５ｈｔ３アンタゴニスト、５ｈｔ４アゴニスト及び緩下薬を含んでなる三種類の組み合わせの使用
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
SI1789067T1 (sl) 2004-08-12 2012-09-28 Helsinn Healthcare Sa Uporaba spojine rastnega hormona sekretagoga za stimulacijo dejavnosti gastrointestinalnega sistema
GB201103397D0 (es) * 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (ja) * 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
NZ511117A (en) * 1998-11-23 2002-11-26 Janssen Pharmaceutica Nv Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Also Published As

Publication number Publication date
EE200100539A (et) 2002-12-16
AU4913700A (en) 2000-11-17
BR0010150A (pt) 2002-01-15
WO2000066170A1 (en) 2000-11-09
JP2002543161A (ja) 2002-12-17
BG65061B1 (bg) 2007-01-31
AU770073B2 (en) 2004-02-12
CZ20013735A3 (cs) 2002-02-13
UA68426C2 (uk) 2004-08-16
US6413988B1 (en) 2002-07-02
CA2371178A1 (en) 2000-11-09
PL195674B1 (pl) 2007-10-31
TR200103121T2 (tr) 2002-05-21
HRP20010764B1 (en) 2011-01-31
NO331448B1 (no) 2012-01-02
NO20014794D0 (no) 2001-10-02
KR20020004972A (ko) 2002-01-16
EP1176982B1 (en) 2003-11-26
MY119880A (en) 2005-07-29
CN1165345C (zh) 2004-09-08
SI1176982T1 (en) 2004-04-30
CA2371178C (en) 2008-03-25
HK1045950B (zh) 2005-05-27
BRPI0010150B8 (pt) 2021-05-25
PT1176982E (pt) 2004-04-30
SK284847B6 (sk) 2006-01-05
DE60006799T2 (de) 2004-09-23
IL146152A0 (en) 2002-07-25
BRPI0010150B1 (pt) 2015-06-23
IL146152A (en) 2006-12-31
NO20014794L (no) 2001-10-02
NZ515119A (en) 2003-05-30
HK1045950A1 (en) 2002-12-20
BG106031A (en) 2002-05-31
PL352062A1 (en) 2003-07-28
CN1348386A (zh) 2002-05-08
SK15192001A3 (sk) 2002-03-05
CZ294070B6 (cs) 2004-09-15
ES2211546T3 (es) 2004-07-16
EP1176982A1 (en) 2002-02-06
DE60006799D1 (de) 2004-01-08
EE05264B1 (et) 2010-02-15
HUP0202324A2 (hu) 2002-12-28
HRP20010764A2 (en) 2002-12-31
EA200101150A1 (ru) 2002-04-25
KR100669175B1 (ko) 2007-01-17
ID30397A (id) 2001-11-29
EA003904B1 (ru) 2003-10-30
HUP0202324A3 (en) 2003-03-28
JP4773619B2 (ja) 2011-09-14
DK1176982T3 (da) 2004-03-29
ATE254929T1 (de) 2003-12-15
ZA200108820B (en) 2003-01-27
HU228924B1 (en) 2013-06-28
TW592709B (en) 2004-06-21
MXPA01010953A (es) 2002-05-06
JO2181B1 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
ITTO20010005A0 (it) Formulazione farmaceutica.
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
BR0001742B1 (pt) embalagem para dispositivo médico.
MXPA03004794A (es) Derivados de acido mandelico y su uso como inhibidores de trombina.
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
EE200300048A (et) Bensimidasooli derivaadid, nende valmistamine ja terapeutiline kasutamine
EE05003B1 (et) Dihdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
AR023815A1 (es) Solucion oral de prucalopride
DK1265577T3 (da) Medicinsk eller dentalmedicinsk behandlingsstol
NO20030998D0 (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler
CY1108053T1 (el) Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου
NO20034524D0 (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
ITRM20010048A0 (it) Metodo per preparare soluzioni acquose fisiologicamente accettabili esoluzioni cosi' ottenute.
ITMI20021771A1 (it) Uso di soluzioni attive per la disinfezione e/o sterilizzazione di un riunito dentale e relativo metodo.
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
ATE317386T1 (de) Dihydroindol- und tetrahydrochinolinderivate
IT1318516B1 (it) Derivati 2-amminotetralinici otticamente attivi, procedimenti per laloro preparazione e impiego terapeutico delle corrispondenti
IT1317850B1 (it) Strumento per la pulizia, in particolare ad uso medicale.
PA8530101A1 (es) Sales metalicas de eteres de ciclo-hexenonoxima
ES1043568Y (es) Cultivador cinetico.
CR6300A (es) Nueva formulacion oral
IT1318844B1 (it) Dispositivo per la conservazione, preparazione e dosaggio di soluzionia preparazione estemporanea.

Legal Events

Date Code Title Description
FG Grant, registration